4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-062490
Director sold 4,730 shares at $24.18 ($114,371)
- Director acquired 4,096 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Welgus Howard G. · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +822 | $6.52 | $5,361 | 37,297 | D |
| 2026-09-15 | Exercise or conversion : show line 2 in the form 10b5-1 | +1,019 | $7.51 | $7,653 | 38,316 | D |
| 2026-09-15 | Exercise or conversion : show line 3 in the form 10b5-1 | +2,255 | $8.63 | $19,461 | 40,571 | D |
| 2026-09-15 | Sale : show line 4 in the form 10b5-1 | −4,730 | $24.18 | $114,371 | 35,841 | D |
| Open-market sales · 4,730 sh · avg $24.18 · $114,371 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-15 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −822 | 6,574 | D |
| 2026-09-15 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −1,019 | 8,144 | D |
| 2026-09-15 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) | −2,255 | 18,032 | D |
Loading xslF345X06/wk-form4_1789675580.xml…